119 |
Epidemiologic Stent-Based Approach to Vulnerable Plaque Stabilization Based on Statistical Modeling of Plaque Rupture and Death |
Richard E. Kuntz |
Jul. 22. 05 |
118 |
Detection and Treatment of Thin Fibrous Cap, Lipid Rich, and Inflammatory Vulnerable Plaque - Angioscopic Evaluation |
Kyoichi Mizuno |
Jul. 22. 05 |
117 |
Coronary Artery Thermography |
Christodoulos Stefanadis |
Jul. 22. 05 |
116 |
Characterization of Coronary Atherosclerotic Plaques Using CTA |
Koen Nieman |
Jul. 22. 05 |
115 |
Erosion, Intraplaque Hemorrhage: The Other Face of Vulnerability |
Renu Virmani |
Jul. 22. 05 |
114 |
Cypher PK study in Japan |
Masato Nakamura |
Jul. 15. 05 |
113 |
Reopro Eluting Stents in Acute Coronary Syndrome |
Myung-Ho Jeong |
Jul. 15. 05 |
112 |
ABT 578 Drug-Eluting Stents II: Preclinical Observations and the Clinical Trial Strategy for the Abbott ZoMax Stent |
Alan C. Yeung |
Jul. 15. 05 |
111 |
Update on Jupiter l and ll Clinical Trials with the Sorin Carbostent Tacrocimus Eluting Stent |
Gian Battista Danzi |
Jul. 15. 05 |
110 |
Terumo DES Program -Nobori 1 Clinical Trial |
Hidehiko Honda |
Jul. 15. 05 |